Brett Kleger, CEO of Datacubed Health: $43 Million Raised to Revolutionize Clinical Trial Data Collection

Welcome to another episode of Category Visionaries — the show that explores GTM stories from tech's most innovative B2B founders. In today's episode, we're speaking with Brett Kleger, CEO of Datacubed Health, a data collection and patient engagement platform that has raised over $43 Million in funding.

Here are the most interesting points from our conversation:

• Background Transformation: Brett shares his journey from a "recovering lawyer" to leading a tech company focused on clinical trials, highlighting his passion for creating a meaningful impact in healthcare.
• Access to Clinical Trials: Datacubed Health aims to democratize access to clinical trials, allowing individuals from any socioeconomic background and location to participate, challenging the traditional model that favored those with proximity to major medical centers and financial means.
• Patient-Centric Approach: The company distinguishes itself by prioritizing patient experience in clinical trials, using behavioral science to engage participants effectively, a shift from viewing patients merely as data sources.
• Navigating a Pandemic: Brett discusses the challenges and strategic shifts needed to adapt Datacubed Health's operations and growth plans in the face of the COVID-19 pandemic, emphasizing the importance of remote work adaptation and employee support.
• Strategic Growth: Key priorities for 2024 include sensible growth, advancing patient data collection sophistication, and achieving profitability, with a focus on expanding market reach within the clinical trial space.
• Vision for the Future: Brett envisions a future where access to cutting-edge medical treatments is not limited by geography or financial status, aiming to make novel healthcare solutions available to all through improved clinical trial processes.